{
    "nctId": "NCT03519568",
    "officialTitle": "Evaluating Immunogenicity and Safety Effect on Combined Immune Effect of EV71 Inactivated Vaccine and HepB\u3001MPSV-A\u3001MR\u3001JE-L\uff1aA Multi-center Randomized Controlled Trial",
    "inclusionCriteria": "Inclusion criteria for group \u2160\uff08HepB:3+EV71\uff09were as follows:\n\n1. aged \u2265 6 months\n2. sign the informed consent form\n3. the legal guardians participate in all the planned follow-up and be able to comply with all research procedures\n4. the subjects have completed the basic immunization of 2 needle recombinant hepatitis B vaccine, there is no inoculation history of EV71 vaccine, and no history of EV71 infection\n5. the last vaccination intervals \u2265 14 days\n6. temperature \u2264 37\u2103\n\nInclusion criteria for group \u2161\uff08MPSV-A:1+EV71\uff09were as follows:\n\n1. aged \u2265 6 months\n2. sign the informed consent form\n3. the legal guardians participate in all the planned follow-up and be able to comply with all research procedures\n4. there is no inoculation history of EV71 vaccine, and there is no history of EV71 infection\n5. the last vaccination intervals \u2265 14 days\n6. temperature \u2264 37\u2103\n\nInclusion criteria for group \u2162\uff08MR+EV71\uff09were as follows:\n\n1. aged \u2265 8 months\n2. sign the informed consent form\n3. the legal guardians participate in all the planned follow-up and be able to comply with all research procedures\n4. there is no inoculation history of EV71 vaccine, and there is no history of EV71 infection\n5. the last vaccination intervals \u2265 14 days and the last attenuated live vaccine intervals\u226528days\n6. temperature \u2264 37\u2103\n\nInclusion criteria for group \u2163\uff08JE-L+EV71\uff09were as follows:\n\n1. aged \u2265 8 months\n2. sign the informed consent form\n3. the legal guardians participate in all the planned follow-up and be able to comply with all research procedures\n4. there is no inoculation history of EV71 vaccine, and there is no history of EV71 infection\n5. the last vaccination intervals \u2265 14 days and the last attenuated live vaccine intervals \u2265 28 days\n6. temperature \u2264 37\u2103\n* Must have minimum age of 6 Months\n* Must have maximum age of 12 Months",
    "exclusionCriteria": "Exclusion criteria for first needle:\n\n1. the history or family history of anaphylaxis, convulsion, epilepsy, encephalopathy and psychosis\n2. the history of severe inoculation allergies\n3. patients with immunodeficiency and malignant tumors during the treatment period, receiving immunosuppressive therapy (oral steroid) or HIV due to low immunity, or family members have congenital immune disease\n4. Nonspecific immunoglobulin was injected within one month\n5. temperature\u226537.1\u2103 and infectious diseases\n6. the history of thrombocytopenia or other thrombocytopenia with a definite diagnosis\n7. respiratory disease, acute infection or chronic disease activity period\n8. severe cardiovascular disease, liver and kidney disease, and complications of diabetes\n9. infectious, suppurative and allergic dermatosis\n10. other conditions that may affect the evaluation of the trail\n\nExclusion criteria for follow-up needle:\n\n1. any serious adverse events that have a causal relationship with the inoculation of the upper dose of the vaccine\n2. the abnormality of 4 levels (local, systemic adverse reactions and vital signs) was judged to be related to vaccination\n3. other new standards of exclusion criteria for first needle\n4. other conditions that may affect the evaluation of the trail"
}